Rici Healthcare Holdings Ltd. (HK:1526)
:1526
Top Page
Rici Healthcare Holdings Ltd.
(1526)
Select Model
Select Model
Rating:66Neutral
Price Target:
HK$0.93
▼(-6.16% Downside)
Action:ReiteratedDate:10/28/25
Rici Healthcare Holdings Ltd. scores well on valuation due to its low P/E ratio and attractive dividend yield, making it appealing for value and income investors. However, financial performance is mixed, with strong profitability offset by revenue decline and high leverage. Technical indicators suggest a bearish trend, which could limit short-term upside potential.
Positive Factors
Strong Profit Margins
The company reports robust gross (39.9%) and net (10.2%) margins, indicating durable operational efficiency in manufacturing and product mix. High margins provide recurring cash buffer to support R&D, product development and withstand pricing pressure in med‑tech markets over the medium term.
Negative Factors
High Leverage
A 1.71 debt/equity ratio implies meaningful financial leverage that increases interest burden and earnings volatility. High leverage limits flexibility for capex or acquisitions, raises refinancing risk, and amplifies downside if revenue weakens or rates rise, pressuring long‑term stability.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Profit Margins
The company reports robust gross (39.9%) and net (10.2%) margins, indicating durable operational efficiency in manufacturing and product mix. High margins provide recurring cash buffer to support R&D, product development and withstand pricing pressure in med‑tech markets over the medium term.
Read all positive factors
Rici Healthcare Holdings Ltd. (1526) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.32B
Dividend Yield4.37%
Average Volume (3M)125.43K
Price to Earnings (P/E)5.3
Beta (1Y)0.27
Revenue Growth-3.56%
EPS Growth-17.45%
CountryHK
Employees8,908
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.17
Shares Outstanding1,590,324,000
10 Day Avg. Volume143,000
30 Day Avg. Volume125,433
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)1.39
Price to Sales (P/S)0.64
P/FCF Ratio3.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Rici Healthcare Holdings Ltd. Business Overview & Revenue Model
Company Description
Rici Healthcare Holdings Ltd. (1526) is a healthcare investment company based in Hong Kong, primarily focusing on the development, manufacturing, and distribution of medical devices and healthcare products. The company operates within the healthca...
How the Company Makes Money
Rici Healthcare generates revenue through multiple streams, including the sale of its proprietary medical devices and healthcare products to hospitals, clinics, and healthcare providers. The company also earns income from partnerships with other h...
Rici Healthcare Holdings Ltd. Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
65
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.27B | 2.92B | 2.99B | 2.38B | 2.38B | 1.93B |
| Gross Profit | 975.27M | 1.17B | 1.25B | 927.20M | 975.22M | 580.66M |
| EBITDA | 651.40M | 798.69M | 1.07B | 572.61M | 682.80M | 234.75M |
| Net Income | 240.30M | 297.32M | 363.80M | 290.79M | 181.55M | -7.88M |
Balance Sheet | ||||||
| Total Assets | 4.72B | 4.86B | 4.64B | 4.57B | 4.54B | 4.21B |
| Cash, Cash Equivalents and Short-Term Investments | 1.03B | 1.12B | 811.21M | 720.14M | 784.36M | 574.86M |
| Total Debt | 2.25B | 2.30B | 2.27B | 2.30B | 2.74B | 2.90B |
| Total Liabilities | 3.30B | 3.48B | 3.52B | 3.66B | 3.95B | 3.88B |
| Stockholders Equity | 1.40B | 1.35B | 1.13B | 953.92M | 677.50M | 505.81M |
Cash Flow | ||||||
| Free Cash Flow | 311.65M | 584.35M | 487.07M | 396.33M | 356.41M | 77.71M |
| Operating Cash Flow | 358.39M | 790.58M | 826.29M | 706.37M | 681.07M | 444.63M |
| Investing Cash Flow | -15.50M | -140.02M | -147.00M | -273.99M | -269.13M | -355.44M |
| Financing Cash Flow | -81.44M | -351.23M | -592.72M | -495.23M | -193.99M | 169.32M |
Rici Healthcare Holdings Ltd. Technical Analysis
Negative
0.99
Price Trends
0.92
Negative
0.95
Negative
1.00
Negative
Market Momentum
-0.01
Negative
41.88
Neutral
64.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1526, the sentiment is Negative. The current price of 0.99 is above the 20-day moving average (MA) of 0.88, above the 50-day MA of 0.92, and below the 200-day MA of 1.00, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 41.88 is Neutral, neither overbought nor oversold. The STOCH value of 64.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1526.
Rici Healthcare Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$678.82M | 3.30 | 5.29% | 9.14% | 0.47% | 50.46% | |
66 Neutral | HK$1.32B | 5.35 | 18.05% | 4.37% | -3.56% | -17.45% | |
56 Neutral | HK$545.87M | 5.00 | 31.63% | ― | 2.30% | ― | |
52 Neutral | HK$311.23M | 4.11 | 3.54% | 3.75% | 9.07% | 8.95% | |
52 Neutral | HK$1.69B | 117.78 | 0.48% | 0.49% | -0.55% | 45.36% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$936.00M | -275.87 | 1.85% | ― | -13.22% | -69.35% |
* Healthcare Sector Average
HK:1526
Rici Healthcare Holdings Ltd.
0.83
-0.27
-24.55%
HK:9906
Honliv Healthcare Management Group Co Ltd
1.56
0.02
1.30%
HK:1419
Human Health Holdings Ltd.
0.82
0.11
15.49%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.03
0.21
11.54%
HK:3869
Hospital Corporation of China Ltd
3.95
-2.85
-41.91%
HK:3886
Town Health International Medical Group Ltd.
0.25
0.02
8.23%
Rici Healthcare Holdings Ltd. Corporate Events
Rici Healthcare Reshapes Board with Independent Director Resignation and New Appointment
Dec 29, 2025
Rici Healthcare Holdings Limited announced that independent non-executive director Dr. Wang Yong has resigned, effective 29 December 2025, stepping down from both the board and the audit committee to focus on other business commitments, with the c...
Rici Healthcare Confirms Board and Committee Line-Up
Dec 29, 2025
Rici Healthcare Holdings Limited has announced the current composition of its board of directors, which comprises four executive directors, including chairman and chief executive officer Dr. Fang Yixin, and three independent non-executive director...
Rici Healthcare Acquires Shanghai Property in Major Transaction
Nov 4, 2025
Rici Healthcare Holdings Ltd., through its wholly-owned subsidiary, has entered into a significant real estate transaction by acquiring a residential property in Shanghai for RMB198,950,940. This acquisition, classified as a discloseable transacti...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.